Xencor, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
ACLX
Arcellx, Inc. |
$60.16 | $3.34 B | -30.35 | 163 |
ANAB
AnaptysBio, Inc. |
$19.06 | $584.51 M | -3.72 | 136 |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $8.19 B | -16.47 | 355 |
DICE
DICE Therapeutics, Inc. |
$47.55 | $2.27 B | -21.91 | 71 |
ERAS
Erasca, Inc. |
$1.18 | $332.84 M | -1.7 | 103 |
EWTX
Edgewise Therapeutics, Inc. |
$13.03 | $1.37 B | -8.99 | 110 |
FIXX
Homology Medicines, Inc. |
$0.93 | $3.02 M | -0.03 | 7 |
GLUE
Monte Rosa Therapeutics, Inc. |
$4.42 | $271.87 M | -4.51 | 134 |
IDYA
IDEAYA Biosciences, Inc. |
$16.19 | $1.42 B | -4.82 | 131 |
KROS
Keros Therapeutics, Inc. |
$13.54 | $549.21 M | -2.71 | 169 |
KURA
Kura Oncology, Inc. |
$5.75 | $464.47 M | -2.85 | 192 |
LRMR
Larimar Therapeutics, Inc. |
$1.84 | $117.81 M | -1.39 | 65 |
MGTX
MeiraGTx Holdings plc |
$5.33 | $420.30 M | -2.51 | 375 |
MLYS
Mineralys Therapeutics, Inc. |
$13.52 | $877.13 M | -3.69 | 51 |
MRUS
Merus N.V. |
$41.92 | $2.90 B | -12.51 | 260 |
NUVL
Nuvalent, Inc. |
$70.01 | $5.01 B | -17.81 | 142 |
PCVX
Vaxcyte, Inc. |
$29.11 | $3.75 B | -7.66 | 414 |
PTGX
Protagonist Therapeutics, Inc. |
$45.87 | $2.82 B | 10.84 | 126 |
REPL
Replimune Group, Inc. |
$7.64 | $588.39 M | -2.49 | 331 |
SNDX
Syndax Pharmaceuticals, Inc. |
$11.05 | $950.79 M | -2.97 | 270 |
STRO
Sutro Biopharma, Inc. |
$0.55 | $45.69 M | -0.18 | 310 |
VRDN
Viridian Therapeutics, Inc. |
$12.66 | $1.03 B | -4.12 | 143 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
